Author, as appears in the article.: Vitallé J, Terrén I, Orrantia A, Pérez-Garay R, Vidal F, Iribarren JA, Rodríguez C, Lirola AML, Bernal E, Zenarruzabeitia O, Borrego F

Department: Medicina i Cirurgia

URV's Author/s: Vidal Marsal, Francisco

Thematic Areas: Medicine (miscellaneous) Medicina iii Medicina ii Medicina i Infectious diseases Immunology and allergy Immunology Farmacia Ciências biológicas i

licence for use: https://creativecommons.org/licenses/by/3.0/es/

ISSN: 16727681

Author's mail: francesc.vidal@urv.cat

Author identifier: 0000-0002-6692-6186

Record's date: 2023-02-18

Papper version: info:eu-repo/semantics/publishedVersion

Link to the original source: https://www.nature.com/articles/s41423-019-0275-4

Licence document URL: http://repositori.urv.cat/ca/proteccio-de-dades/

Papper original source: Cellular & Molecular Immunology. 16 (12): 940-942

APA: Vitallé J, Terrén I, Orrantia A, Pérez-Garay R, Vidal F, Iribarren JA, Rodríguez C, Lirola AML, Bernal E, Zenarruzabeitia O, Borrego F (2019). CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients. Cellular & Molecular Immunology, 16(12), 940-942. DOI: 10.1038/s41423-019-0275-4

Article's DOI: 10.1038/s41423-019-0275-4

Entity: Universitat Rovira i Virgili

Journal publication year: 2019

Publication Type: Journal Publications